Name: FORMYCON AG (FYB) Stock
Brand: FORMYCON AG
Rating: 5.5 (3 reviews)

Question 1

What does FORMYCON AG do?

Accepted Answer

Formycon AG engages in the manufacture of biosimilar drugs and formulations. The company is headquartered in Martinsried, Bayern and currently employs 245 full-time employees. The company went IPO on 2010-12-20. The firm is engaged in providing biosimilar drugs and formulations. The firm focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.

Question 2

What is the stock price of FORMYCON AG today?

Accepted Answer

The current stock price of FYB.DE is 24.25 EUR. The price increased by 0.21% in the last trading session.

Question 3

Does FYB stock pay dividends?

Accepted Answer

FYB.DE does not pay a dividend.

Question 4

What is the ChartMill technical and fundamental rating of FYB stock?

Accepted Answer

FYB.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.

Question 5

On which exchange is FYB.DE stock listed?

Accepted Answer

FYB.DE stock is listed on the Frankfurt Stock Exchange exchange.

Question 6

What is the market capitalization of FYB stock?

Accepted Answer

FORMYCON AG (FYB.DE) has a market capitalization of 428.50M EUR. This makes FYB.DE a Small Cap stock.

Question 7

Can you provide the ownership details for FYB stock?

Accepted Answer

You can find the ownership structure of FORMYCON AG (FYB.DE) on the Ownership tab.

FORMYCON AG (FYB.DE) Stock Price, Forecast & Analysis

FYB.DE Latest News, Press Relases and Analysis